Sugiyama Toru, Yoshimoto Takanobu, Sato Ryuji, Fukai Nozomi, Ozawa Naoko, Shichiri Masayoshi, Hirata Yukio
Department of Clinical and Molecular Endocrinology, Tokyo Medical and Dental University Graduate School, Tokyo, Japan.
J Cardiovasc Pharmacol. 2004 Nov;44 Suppl 1:S332-5. doi: 10.1097/01.fjc.0000166267.17174.0e.
Since both endothelin-1 (ET-1) and aldosterone have been shown to induce expression of several pro-inflammatory genes, including cyclooxygenase-2 (COX-2), in the vasculature as a cardiovascular risk hormone, the present study was undertaken to examine the effects of ET-1 and aldosterone on COX-2 gene expression as measured by a real-time reverse transcriptase-polymerase chain reaction in aortic endothelial cells. Treatment with ET-1(10 M) markedly upregulated COX-2 mRNA levels in rat endothelial cells, whereas aldosterone (10 M) did not show any effect. The ET-1-induced COX-2 upregulation was inhibited by pretreatment with a non-selective endothelin receptor antagonist (TAK044), a protein kinase C inhibitor (GF109203X), and a MEK inhibitor (PD98059). Furthermore, ET-1 increased intracellular reactive oxygen species generation as estimated by the measurement of dichlorofluorescein fluorescence, whose effect was blocked by a COX-2 inhibitor (NS398). Our data show that ET-1 induces COX-2 upregulation in rat endothelial cells via a protein kinase C-dependent and extracellular signal-regulated kinase-dependent pathway, which may largely contribute to the generation of intracellular reactive oxygen species.
内皮素-1(ET-1)和醛固酮作为心血管风险激素,已被证明可诱导包括血管内皮细胞中环氧合酶-2(COX-2)在内的多种促炎基因的表达。因此,本研究旨在通过实时逆转录聚合酶链反应检测ET-1和醛固酮对主动脉内皮细胞中COX-2基因表达的影响。用ET-1(10 μM)处理可显著上调大鼠内皮细胞中COX-2 mRNA水平,而醛固酮(10 μM)则无任何作用。用非选择性内皮素受体拮抗剂(TAK044)、蛋白激酶C抑制剂(GF109203X)和MEK抑制剂(PD98059)预处理可抑制ET-1诱导的COX-2上调。此外,通过测量二氯荧光素荧光估计,ET-1可增加细胞内活性氧的产生,而COX-2抑制剂(NS398)可阻断其作用。我们的数据表明,ET-1通过蛋白激酶C依赖性和细胞外信号调节激酶依赖性途径诱导大鼠内皮细胞中COX-2上调,这可能在很大程度上促进细胞内活性氧的产生。